RHETA THOMAS: Open Payments
NPI 1447718226 · MCCOMB, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,847 in 96 payments from 14 companies in 2025. Trend: 2023 $1,152 · 2024 $1,617 · 2025 $1,847
Food & beverage: $1,763Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $610 |
| Janssen Biotech, Inc. | 21 | $496 |
| Regeneron Healthcare Solutions, Inc. | 5 | $152 |
| QOL Medical, LLC | 5 | $125 |
| Ardelyx, Inc. | 6 | $114 |
| Phathom Pharmaceuticals, Inc. | 4 | $95 |
| Madrigal Pharmaceuticals | 4 | $64 |
| Gilead Sciences, Inc. | 3 | $59 |
| EVOKE PHARMA, INC. | 2 | $36 |
| PFIZER INC. | 1 | $27 |
Products named: TREMFYA, RINVOQ, DUPIXENT, Sucraid, IBSRELA, CREON, VOQUEZNA, LINZESS.
Industry payments across MS — which companies pay providers there.
